Human models for studying malignant progression in breast cancer.
Taylor-Papadimitriou
J
J
Imperial Cancer Research Fund, London, UK.
D'Souza
B
B
Berdichevsky
F
F
Shearer
M
M
Martignone
S
S
Alford
D
D
D001940:Breast / Q000737:chemistry / Q000473:pathology*; D001943:Breast Neoplasms / Q000737:chemistry / Q000235:genetics / Q000473:pathology*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000737:chemistry / Q000235:genetics / Q000473:pathology*; D004848:Epithelium / Q000737:chemistry / Q000473:pathology; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016023:Integrins / Q000032:analysis; D007381:Intermediate Filament Proteins / Q000032:analysis; D008895:Milk, Human / Q000166:cytology; D008954:Models, Biological; D010641:Phenotype; D011518:Proto-Oncogene Proteins / Q000032:analysis; D018719:Erb-b2 Receptor Tyrosine Kinases; D014407:Tumor Cells, Cultured
D066246:ErbB Receptors; D016023:Integrins; D007381:Intermediate Filament Proteins; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases